- Home
- SRZN vs ORMP Comparison
SRZN vs ORMP Comparison
Compare SRZN & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- ORMP
- Stock Information
- Founded
- SRZN 2015
- ORMP 2002
- Country
- SRZN United States
- ORMP United States
- Employees
- SRZN N/A
- ORMP N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- SRZN Health Care
- ORMP Health Care
- Exchange
- SRZN Nasdaq
- ORMP Nasdaq
- Market Cap
- SRZN 97.3M
- ORMP 93.9M
- IPO Year
- SRZN N/A
- ORMP N/A
- Fundamental
- Price
- SRZN $11.55
- ORMP $2.27
- Analyst Decision
- SRZN Strong Buy
- ORMP
- Analyst Count
- SRZN 2
- ORMP 0
- Target Price
- SRZN $38.50
- ORMP N/A
- AVG Volume (30 Days)
- SRZN 12.2K
- ORMP 91.7K
- Earning Date
- SRZN 11-05-2025
- ORMP 11-06-2025
- Dividend Yield
- SRZN N/A
- ORMP N/A
- EPS Growth
- SRZN N/A
- ORMP N/A
- EPS
- SRZN N/A
- ORMP N/A
- Revenue
- SRZN $12,621,000.00
- ORMP $2,000,000.00
- Revenue This Year
- SRZN N/A
- ORMP N/A
- Revenue Next Year
- SRZN N/A
- ORMP N/A
- P/E Ratio
- SRZN N/A
- ORMP N/A
- Revenue Growth
- SRZN N/A
- ORMP N/A
- 52 Week Low
- SRZN $5.90
- ORMP $1.82
- 52 Week High
- SRZN $18.17
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- SRZN 53.57
- ORMP 54.03
- Support Level
- SRZN $11.25
- ORMP $2.17
- Resistance Level
- SRZN $11.74
- ORMP $2.45
- Average True Range (ATR)
- SRZN 0.59
- ORMP 0.06
- MACD
- SRZN -0.13
- ORMP 0.01
- Stochastic Oscillator
- SRZN 21.37
- ORMP 43.75
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.